Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study.
about
Collaborative cancer epidemiology in the 21st century: the model of cancer consortiaGermline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.Personalized prostate cancer screening among men with high risk genetic predisposition- study protocol for a prospective cohort study.Implications of High Rates of Metastatic Prostate Cancer in BRCA2 Mutation CarriersTargeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT studyGenome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population.National Cancer Institute Prostate Cancer Genetics WorkshopHereditary breast and ovarian cancer: new genes, new treatments, new concepts.BRCA1/2 genetic testing uptake and psychosocial outcomes in men.Cancer worry among Norwegian male BRCA1/2 mutation carriers.A comprehensively molecular haplotype-resolved genome of a European individualInterest of individuals from BRCA families to participate in research studies focused on male BRCA carriersSecondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes.An inherited NBN mutation is associated with poor prognosis prostate cancerA personalised approach to prostate cancer screening based on genotyping of risk founder allelesThe role of BRCA1 and BRCA2 in prostate cancer.Familial prostate cancer: the damage done and lessons learnt.Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control studyA Paternally Inherited BRCA1 Mutation Associated with an Unusual Aggressive Clinical Phenotype.Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease.BRCA1 and BRCA2 - update and implications on the genetics of breast cancer: a clinical perspective.EN2: a novel prostate cancer biomarker.The genetic epidemiology of prostate cancer and its clinical implications.Li-Fraumeni syndrome: cancer risk assessment and clinical management.Prostate cancer: measuring PSA.Silencing of BRCA2 decreases anoikis and its heterologous expression sensitizes yeast cells to acetic acid-induced programmed cell death.Translating genetic risk factors for prostate cancer to the clinic: 2013 and beyond.IMPACT Study: Targeted Prostate Cancer Screening.Update on Screening for Urological Malignancies.Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men.The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland.Germline BRCA mutation in male carriers-ripe for precision oncology?Is there a difference in testosterone levels and its regulators in men carrying BRCA mutations?Male BRCA mutation carriers: clinical characteristics and cancer spectrum.Men with a susceptibility to prostate cancer and the role of genetic based screening.Aberrations of DNA Repair Pathways in Prostate Cancer: Future Implications for Clinical Practice?Spontaneous antibodies against Engrailed-2 (EN2) protein in patients with prostate cancer
P2860
Q27022338-F38F2EBF-4FBB-4791-882D-EF3175BB6E72Q27852185-C32FA270-2734-4FA4-8164-C032B41C7077Q30597063-DE1CBD4D-213E-4AD2-9B05-433BDF64C03EQ33796352-9B421C7C-A937-4E50-93CF-2C2BDED961FDQ33927384-38B81980-FE06-44D2-B17E-8ED3190FB24AQ34650062-08B94D7D-63E4-44A3-AFB2-977D126F500AQ34988026-CC780D7F-48A7-4638-8880-87932D7624C1Q35019634-579BB884-A9B5-4A67-BC99-D1503A6377D0Q35131147-E0767698-88E5-4DCF-BEE7-A1FFCE71929AQ35219186-72B1286B-E9DE-48B2-ABF4-CEFD483891F7Q35451799-8CE8658E-ED4C-49B4-ACF0-BC0F1D968722Q35907075-7AA6C1AA-590C-4E88-8AA0-65BAF840ABF8Q36096070-5AD5BD6B-BAF5-41D8-81DD-EE9D35AEC530Q36594121-57C81EC9-F82A-47C7-80C8-0A741068267DQ36959139-C7B06D84-6EBA-4C8E-99C7-113337A3754EQ37037789-68AE1061-5381-46DC-B36E-11DF2C914D19Q37553869-50346BC3-2B6E-49DC-B6F3-218EA1A0FF0CQ37600503-F5E57669-A721-469C-A04C-6FEDEE54AD07Q37602441-5E56CF43-2BDE-4071-8933-37F7A374CFE7Q37650650-B6F3C970-0E7F-4D81-ACDC-459593D364BBQ38151730-D2E4804C-AE2C-4079-AE4C-0B1579BC24CBQ38165246-17207A6D-942F-45B4-8807-E8D4C955FAFCQ38168060-7D6411B5-8225-47F8-8E29-D93406CCE7B2Q38197030-B72DABB4-FA09-4391-84F5-1F3FBAF6E0B4Q38210857-B8AF918C-B714-4CA5-BCB0-ACD1CFDFCCE3Q38987920-6149A4EA-301F-4C45-8634-EE862A152B93Q39141778-14918A37-8EE4-47EF-9BF3-B4E5324DDD81Q42575274-94D169A4-FD27-4079-ADA6-5EB3E9425744Q42649779-02FFE445-45ED-492D-BA3E-C0A13CFA4290Q43052119-E689FB98-C500-48B2-876C-77EAE701FE7CQ44733776-B16D9A90-594A-4F89-874F-6BB9B84BB9DFQ46798905-6997E45B-7021-4E91-9ABE-2A6C681D3F7AQ47141403-6C5FC87A-C399-478A-BC47-BF8429FFD2A4Q49290359-80CF3FD2-017A-4874-9924-83E19F48AFA8Q53423427-75F2110B-96A7-41B8-AC82-C52A02B19176Q57106332-C66F2279-C6BB-4977-847E-D15B010659C1Q57694335-C2120729-31F7-49AF-B9BE-ED919494DB87
P2860
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Targeted prostate cancer scree ...... e results of the IMPACT study.
@en
Targeted prostate cancer scree ...... e results of the IMPACT study.
@nl
type
label
Targeted prostate cancer scree ...... e results of the IMPACT study.
@en
Targeted prostate cancer scree ...... e results of the IMPACT study.
@nl
prefLabel
Targeted prostate cancer scree ...... e results of the IMPACT study.
@en
Targeted prostate cancer scree ...... e results of the IMPACT study.
@nl
P2093
P2860
P50
P1433
P1476
Targeted prostate cancer scree ...... e results of the IMPACT study.
@en
P2093
A Ardern-Jones
A Donaldson
A Falconer
A Liljegren
A Spigelman
A Stapleton
Anita V Mitra
P2860
P356
10.1111/J.1464-410X.2010.09648.X
P50
P577
2010-09-14T00:00:00Z